The global intravascular stents market is segmented by type, mode of delivery, product, and end-use.
Drug Eluting Stents:
Drug eluting stents segment is expected to witness significant growth due to the increasing prevalence of cardiovascular diseases and the growing adoption of minimally invasive procedures. These stents are coated with medication to prevent restenosis and improve patient outcomes.
Bare Metal Stents:
Bare metal stents are also a prominent segment in the market, especially in emerging economies where cost plays a crucial role in treatment decisions. These stents are known for their simplicity and ease of use, making them a preferred choice in certain patient populations.
Mode of Delivery:
The market is further segmented based on the mode of delivery, including balloon expandable stents and self-expandable stents. Balloon expandable stents are widely used for precise placement and controlled deployment, while self-expandable stents offer flexibility and adaptability in complex anatomies.
Product:
The intravascular stents market is diversified based on product types such as coronary stents, peripheral stents, and neurovascular stents. Coronary stents hold the largest market share, driven by the high incidence of coronary artery diseases and the availability of advanced technologies for stent placement.
End-Use:
Hospitals, cardiac centers, and ambulatory surgical centers are key end-users in the intravascular stents market. Hospitals dominate the market share due to the availability of skilled healthcare professionals, advanced infrastructure, and the rising number of coronary intervention procedures performed in hospital settings.